HCPCS Level II › J codes J7680 Terbutaline sulf comp conTerbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
Medicare coverage: Special coverage instructions apply Status: active (October 2026 file) Medically Unlikely Edits (effective October 1, 2026) Practitioner: max 0 units per day (clinical), rationale: Compounded Drug Policy Outpatient hospital: max 0 units per day (clinical), rationale: Compounded Drug Policy DME supplier: max 0 units per day (clinical), rationale: Compounded Drug Policy Medicare pricing for J7680 Physician Fee Schedule (CY 2026, RVU26D) Status E: excluded from the PFS by regulation.
Payer policies and prior authorization for J7680 Medicaid fee-for-service Prior authorization required or conditional in IN.
OH: $4.44 (provider_administered_drugs), effective Dec 15, 2002 VA: $0.01 (medical), effective Jul 1, 2005 VT: $0.00 (outpatient_hospital_opps), effective Feb 1, 2026 WA: $1.80 (professional_administered_drugs), effective Jul 1, 2026 WY: $0.00 (outpatient_hospital_apc, Children's Hospitals), effective Apr 1, 2026 From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.